MedTrace Logo

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

NCT01346280 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1079

Last updated 2019-12-17

No results posted yet for this study

Summary

Background:

-Coordinated cancer care provided by doctors, nurses, social workers, and other care providers is believed to improve patient and physician satisfaction and patient evaluation for enrollment in clinical trials. But no research has been done to show that this approach improves patient experiences and outcomes. Researchers want to study this model to better understand how it can improve cancer treatment and patient outcomes.

Objectives:

\- To assess the relationship between coordinated care and cancer treatment processes and outcomes.

Eligibility:

\- Individuals who are at least 18 years of age. Those who take part must have been diagnosed with colon, rectal, or non-small-cell lung cancer. They also must be receiving or have been treated at one of the 16 NCI Community Cancer Center program sites.

Design:

* Researchers will collect medical records data from participants.
* Participants will complete a questionnaire about 8 weeks after the end of all planned cancer treatment. They will be asked questions about their experience with coordinated cancer care. They will also be asked for any comments or concerns they had during and after treatment.
* No treatment or additional tests will be provided as part of this protocol.

Conditions

  • Non-Small Cell Lung Cancer (Stage III)
  • Colon Cancer (Stage II &Amp; III)
  • Rectal Cancer (Stage III)

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Kathleen Castro, R.N. · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-16
Completion
2015-10-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01346280 on ClinicalTrials.gov